General Information of the Compound
Compound ID
CP0054338
Compound Name
CAS No.:1352792-74-5
    Show/Hide
Synonyms
RDEA3170
    Show/Hide
Structure
Formula
C20H16N2O2S
Molecular Weight
348.427
Canonical SMILES
CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(O)=O
    Show/Hide
InChI
InChI=1S/C20H16N2O2S/c1-20(2,19(23)24)25-18-9-10-22-12-17(18)16-8-7-13(11-21)14-5-3-4-6-15(14)16/h3-10,12H,1-2H3,(H,23,24)
    Show/Hide
InChIKey
YYBOLPLTQDKXPM-UHFFFAOYSA-N
CAS
1352792-74-5
Physicochemical Property
logP
4.72878
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
73.98
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 54767229
SID: 131531801
ChEMBL ID
CHEMBL3707347
DrugBank ID
DB11873
Clinical Information about the Compound
Drug 1 ( RDEA3170 )
Drug Name RDEA3170
Company AstraZeneca
Indication
Hyperuricaemia
Phase 2
Target(s)
Urate anion exchanger 1 (URAT1)
Modulator